These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 2689969)

  • 1. Benfluorex action on metabolic control and insulin sensitivity in type 2 non-insulin dependent diabetics.
    Pasquali R; Colella P; Capelli M; Zannarini L; Melchionda N; Barbara L
    Panminerva Med; 1989; 31(3):114-8. PubMed ID: 2689969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of benfluorex on insulin secretion and insulin action in streptozotocin-diabetic rats.
    Portha B; Serradas P; Bailbé D; Blondel O; Picarel F
    Diabetes Metab Rev; 1993 Nov; 9 Suppl 1():57S-63S. PubMed ID: 8299491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benfluorex in obese noninsulin dependent diabetes mellitus patients poorly controlled by insulin: a double blind study versus placebo.
    Pontiroli AE; Pacchioni M; Piatti PM; Cassisa C; Camisasca R; Pozza G
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3727-32. PubMed ID: 8855830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benfluorex decreases insulin resistance and improves lipid profiles in obese type 2 diabetic patients.
    Bianchi R; Bongers V; Bravenboer B; Erkelens DW
    Diabetes Metab Rev; 1993 Nov; 9 Suppl 1():29S-34S. PubMed ID: 8299486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Added benfluorex in obese insulin-requiring type 2 diabetes.
    Leutenegger M; Bauduceau B; Brun JM; Guillon-Metz F; Martin C; Nicolino-Peltier C; Richard JL; Vannereau D
    Diabetes Metab; 1998 Feb; 24(1):55-61. PubMed ID: 9534010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benfluorex normalizes hyperglycemia and reverses hepatic insulin resistance in STZ-induced diabetic rats.
    Serradas P; Blondel O; Bailbe D; Portha B
    Diabetes; 1993 Apr; 42(4):564-70. PubMed ID: 8454107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mechanisms of hypoglycemic action of benfluorex].
    Vigili de Kreutzenberg S; Riccio A; Dorella M; Da Tos V; Del Prato S
    Presse Med; 1992 Sep; 21(28):1340-3. PubMed ID: 1438104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benfluorex and blood glucose control in non insulin-dependent diabetic patients.
    Cavallo-Perin P; Estivi P; Boine L; Galletti R; Pacini G; Cobelli C; Pagano G
    J Endocrinol Invest; 1991 Feb; 14(2):109-13. PubMed ID: 2061566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effect of benfluorex in type II diabetic patients on diet regimen alone.
    Velussi M; Monte AD; Cernigoi AM
    J Diabetes Complications; 1996; 10(5):261-6. PubMed ID: 8887014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antidiabetic efficacy of benfluorex. Clinical data].
    Brun JM
    Presse Med; 1992 Sep; 21(28):1344-52. PubMed ID: 1438105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-hyperglycaemic mechanisms of benfluorex in type II diabetes mellitus.
    De Feo P; Lavielle R; De Gregoris P; Bolli GB
    Diabetes Metab Rev; 1993 Nov; 9 Suppl 1():35S-41S. PubMed ID: 8299487
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanism(s) of the blood glucose lowering action of benfluorex.
    Riccio A; Vigili de Kreutzenberg S; Dorella M; Da Tos V; De Biasi L; Marescotti MC; Tiengo A; Del Prato S
    Diabetes Metab Rev; 1993 Nov; 9 Suppl 1():19S-27S. PubMed ID: 8299485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mode of action of benfluorex. Recent data].
    Brindley DN
    Presse Med; 1992 Sep; 21(28):1330-5. PubMed ID: 1438102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms for the effects of benfluorex on the obese-diabetic-dyslipidemic syndrome.
    Brindley DN
    Diabetes Metab Rev; 1993 Nov; 9 Suppl 1():51S-56S. PubMed ID: 8299490
    [No Abstract]   [Full Text] [Related]  

  • 15. Insulin resistance, hyperinsulinemia and diabetes--contribution of benfluorex. Prague, 11 September 1992. Symposium proceedings.
    Diabetes Metab Rev; 1993 Nov; 9 Suppl 1():1S-79S. PubMed ID: 8299483
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of benfluorex in obese patients with metabolic disorders.
    di Martino G; Federico P; Mattera E; Jacono G
    Br J Clin Pract; 1989 Jun; 43(6):201-8. PubMed ID: 2597599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoglycemic effect of fenfluramine in insulin-treated diabetics.
    Hamet P; Verdy I; Chiasson JL; Verdy M
    Clin Invest Med; 1986; 9(1):12-4. PubMed ID: 3514018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of benfluorex on insulin resistance and lipid metabolism in obese type II diabetic patients.
    Bianchi R; Bongers V; Bravenboer B; Erkelens DW
    Diabetes Care; 1993 Apr; 16(4):557-9. PubMed ID: 8462377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiatherogenic effects of long-term benfluorex treatment in male insulin resistant JCR:LA-cp rats.
    Russell JC; Graham SE; Dolphin PJ; Amy RM; Wood GO; Brindley DN
    Atherosclerosis; 1997 Jul; 132(2):187-97. PubMed ID: 9242964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Insulin resistance and insulin secretion in type II non-obese diabetics].
    Pelikánová T; Válek J; Kazdová L; Saudek F; Karasová L
    Cas Lek Cesk; 1994 Mar; 133(6):172-6. PubMed ID: 8156572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.